Clinical Trial Update: Phase II Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine [Phase 2]

View source ↗

Summary

Phase II trial of a 24-valent pneumococcal polysaccharide-conjugate vaccine is underway, with the study currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• 24-valent pneumococcal polysaccharide conjugate vaccine (pneumococcal polysaccharide conjugate vaccine (24-valent))

Snippet

Sponsor: Shanghai Reinovax Biologics Co.,LTD | Conditions: Pneumococcal Infectious Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING